| VYDRA, Jan, C SALEK, J SCHWARZ, Petr CETKOVSKÝ, Pavel ŽÁK, Jan NOVÁK, Veronika PETEČUKOVÁ, Jiří MAYER a Zdeněk RÁČIL. Postremission therapy for AML with intermediate risk cytogenetics in first complete remission. In Haematologica. 2017. ISSN 0390-6078. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{1402099,
author = {Vydra, Jan and SALEK, C and SCHWARZ, J and Cetkovský, Petr and Žák, Pavel and Novák, Jan and Petečuková, Veronika and Mayer, Jiří and Ráčil, Zdeněk},
booktitle = {Haematologica},
language = {eng},
title = {Postremission therapy for AML with intermediate risk cytogenetics in first complete remission.},
year = {2017}
}
TY - CONF
ID - 1402099
AU - Vydra, Jan - SALEK, C - SCHWARZ, J - Cetkovský, Petr - Žák, Pavel - Novák, Jan - Petečuková, Veronika - Mayer, Jiří - Ráčil, Zdeněk
PY - 2017
TI - Postremission therapy for AML with intermediate risk cytogenetics in first complete remission.
ER -
VYDRA, Jan, C SALEK, J SCHWARZ, Petr CETKOVSKÝ, Pavel ŽÁK, Jan NOVÁK, Veronika PETEČUKOVÁ, Jiří MAYER a Zdeněk RÁČIL. Postremission therapy for AML with intermediate risk cytogenetics in first complete remission. In \textit{Haematologica}. 2017. ISSN~0390-6078.
|
